{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:27:24Z","timestamp":1740104844845,"version":"3.37.3"},"reference-count":31,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has become a valuable treatment strategy for selected patients with peritoneal carcinomatosis (PC). In Chile, it is an emerging technique. The aim of this study is to describe our protocol and report our perioperative results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospectively maintained database for patients undergoing exploratory surgery for PC was reviewed. Eligible patients were selected using the peritoneal cancer index in correlation with the primary tumor. Patients underwent HIPEC using mitomycin C. Clinical data and postoperative results were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventy\u2010six patients underwent exploratory surgery. Most patients were female (55%) with a median age of 62 years (range, 25\u201383). Complete CRS and HIPEC were achieved in 53 patients. The most frequent primary tumor site was colon\u2013rectum (49%). The median number of resected organs was 4 (range, 1\u201313). Overall 90\u2010day incidence of major complications was 26%. After a median follow\u2010up of 26 months, 44 patients (83%) in the resected group were alive with no evidence of disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The PC treatment program at our institution has been established in a safe manner, with acceptable morbidity comparable to high\u2010volume centers. A comprehensive preoperative evaluation, careful patient selection, and a cohesive team are necessary for successful results.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jso.26626","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T16:00:27Z","timestamp":1627574427000},"page":"1154-1160","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Starting a peritoneal carcinomatosis treatment program in a developing country: A prospective analysis"],"prefix":"10.1002","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3775-0465","authenticated-orcid":false,"given":"Jorge A.","family":"Gajardo","sequence":"first","affiliation":[{"name":"Gastrointestinal Surgical Oncology Service Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez  Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Matute","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgical Oncology Service Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez  Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Charles","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgical Oncology Service Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez  Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Devaud","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgical Oncology Service Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez  Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Hoefler","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgical Oncology Service Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez  Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Schmied","sequence":"additional","affiliation":[{"name":"Anesthesia Service Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez  Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniella","family":"Rigo\u2010Righi","sequence":"additional","affiliation":[{"name":"Anesthesia Service Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez  Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Butte","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgical Oncology Service Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez  Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i39.5489"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28373"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.06.007"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2005.17.6.668"},{"key":"e_1_2_7_7_1","first-page":"62","article-title":"Pharmacokinetic rationale for peritoneal drug administration","volume":"62","author":"Dedrick R","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(03)00031-0"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v2.i2.68"},{"issue":"5","key":"e_1_2_7_10_1","first-page":"1916","article-title":"Portal levels and hepatic clearance of 5\u2010fluorouracil after intraperitoneal administration in humans","volume":"41","author":"Speyer JL","year":"1981","journal-title":"Cancer Res"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1247-5_23"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-015-1236-x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2006.08.024"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199502000-00002"},{"issue":"2","key":"e_1_2_7_17_1","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt JS","year":"1980","journal-title":"Cancer Res"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-5081-3"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.187"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-9966-2"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.03.030"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1631-5"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.06.029"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2017.1337238"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23231"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.10.007"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181a45d86"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/000313481207800932"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3181a58d56"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9285"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9640"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30599-4"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.26626","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jso.26626","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.26626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T07:28:25Z","timestamp":1693207705000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.26626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1002\/jso.26626"],"URL":"https:\/\/doi.org\/10.1002\/jso.26626","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"type":"print","value":"0022-4790"},{"type":"electronic","value":"1096-9098"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"assertion":[{"value":"2021-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}